In arteritic anterior ischemic optic neuropathy (AAION), which test is used to monitor systemic inflammation to guide therapy?

In arteritic anterior ischemic optic neuropathy (AAION), which test is used to monitor systemic inflammation to guide therapy?

• A. RNFL OCT
• B. ESR/CRP/CBC with differential
• C. TA biopsy
• D. Palpation of temporal artery

Answer: (B)

In arteritic anterior ischemic optic neuropathy, driven by giant cell arteritis, you treat systemic inflammation with medications like high-dose steroids and then tailor therapy by watching inflammatory activity. The most informative way to do this is with a laboratory panel that reflects current inflammation: ESR, CRP, and a CBC with differential. ESR and CRP are direct markers of inflammation that rise with active vasculitis and usually fall as the inflammation comes under control with treatment. They provide quick feedback on whether the disease is still active or responding, which helps determine how aggressively to maintain or taper therapy. The CBC with differential adds information about systemic inflammatory effects, such as anemia of chronic disease and changes in white blood cells or platelets, which often accompany active inflammation and tend to normalize as control is achieved. Other options don’t monitor systemic inflammation in the same way. RNFL OCT measures structural aspects of the optic nerve and retina, not inflammatory activity. Temporal artery biopsy confirms the diagnosis but isn’t useful for ongoing monitoring or guiding therapy. Palpation of the temporal artery is a clinical exam finding used in the initial assessment, not a reliable marker for tracking inflammation over time. So, tracking ESR, CRP, and CBC with differential provides the best, most practical readout to guide systemic treatment in AAION.

In arteritic anterior ischemic optic neuropathy, driven by giant cell arteritis, you treat systemic inflammation with medications like high-dose steroids and then tailor therapy by watching inflammatory activity. The most informative way to do this is with a laboratory panel that reflects current inflammation: ESR, CRP, and a CBC with differential.

ESR and CRP are direct markers of inflammation that rise with active vasculitis and usually fall as the inflammation comes under control with treatment. They provide quick feedback on whether the disease is still active or responding, which helps determine how aggressively to maintain or taper therapy. The CBC with differential adds information about systemic inflammatory effects, such as anemia of chronic disease and changes in white blood cells or platelets, which often accompany active inflammation and tend to normalize as control is achieved.

Other options don’t monitor systemic inflammation in the same way. RNFL OCT measures structural aspects of the optic nerve and retina, not inflammatory activity. Temporal artery biopsy confirms the diagnosis but isn’t useful for ongoing monitoring or guiding therapy. Palpation of the temporal artery is a clinical exam finding used in the initial assessment, not a reliable marker for tracking inflammation over time.

So, tracking ESR, CRP, and CBC with differential provides the best, most practical readout to guide systemic treatment in AAION.